Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2025 09:00 ET | Source: Palisade Bio, Inc.

Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108

– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan – Segment provides further insight into the need for more...
August 19, 2025 10:00 ET | Source: NewBeingNutrition

Florida's Chronic Disease Crisis Gets New Ally: NewBeingNutrition.com Launches to Connect Patients with Integrated Doctor-Dietitian Care Teams

Miami, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- As 6 in 10 American adults battle at least one chronic disease, a new health platform, NewBeingNutrition.com, launched today in Florida to tackle a...
August 14, 2025 10:25 ET | Source: Research and Markets

Smart Pills Company Evaluation Report 2025 | Medtronic, Olympus, and CapsoVision Lead with Minimally Invasive and AI-Enhanced Medical Technologies

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Smart Pills Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Smart Pills Companies Quadrant is a comprehensive...
August 07, 2025 16:05 ET | Source: Ventyx Biosciences, Inc.

Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress

Positive topline Phase 2a biomarker data position VTX3232 as a potential disease-modifying therapy for patients with Parkinson’s disease Data from the Phase 2 study of VTX2735 in patients with...
August 05, 2025 16:02 ET | Source: Spyre Therapeutics, Inc.

Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Reported positive interim Phase 1 results for two next-generation TL1A antibodies, demonstrating both were well-tolerated, exhibited pharmacokinetic ("PK") profiles supporting quarterly or biannual...
August 01, 2025 08:30 ET | Source: SNS Insider pvt ltd

Fecal Calprotectin Testing Market to Hit USD 12.23 Billion by 2032, Driven by Rising Prevalence of IBD and Demand for Non-Invasive Diagnostic Tools - SNS Insider

Austin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Fecal Calprotectin Testing Market Size & Trends: According to SNS Insider, the global Fecal Calprotectin Testing Market was valued at USD 4.51 billion...
July 29, 2025 04:31 ET | Source: Research and Markets

North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers

Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "North America Autoimmune Disease Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
June 27, 2025 04:06 ET | Source: Research and Markets

Immunomodulator Therapeutics Global Market Research 2024-2030 | Investment in R&D Fuels Next-Gen Immunomodulator Therapies Amid Rising Autoimmune Cases

Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The "Immunomodulator Therapeutics Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering. Revenue estimate for the base...
June 24, 2025 07:04 ET | Source: Yorkshire Publishing

Local Author M.B. Mooney Writes Children’s Book to Raise Awareness About Crohn’s Disease

Yorkshire Publishing announces the release of The Mouse Who Couldn’t Eat Cheese, a highly-anticipated children’s picture book written by M.B. Mooney.
June 23, 2025 05:10 ET | Source: Research and Markets

Hydrogels for Future Healthcare (Medical, Fitness, Wellness, Veterinary) Analysis Report 2025-2045: Opportunities, and Strategic Insights to Excel in the Evolving Market

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Hydrogels for Future Healthcare: Medical, Fitness, Wellness, Veterinary Applications 2025-2045" report has been added to ResearchAndMarkets.com's...